Short Squeeze - CMMB Alış

Chemomab Therapeutics Ltd.NASDAQ

Açıklama

⋅ 26 May 2021 15:26

Idea for Chemomab Therapeutics Ltd.:
- 131% borrow fee for shares. 47 shares available for borrow, according to iborrowdesk.

- Bottom of Risk Range:

- S3 Filing Sales Agreement with Cantor Fitzgerald & Co. dated Apr 30, 2021. fintel.io/doc/sec-chemomab-therapeutics-ltd-ex12-2021-april-30-18747-818
- Cantor Fitzgerald assigned overweight rating on CMMB and raised price target to $45. marketbeat.com/ratings/by-issuer/cantor-fitzgerald-stock-recommendations/
- Good short squeeze material.
- Non Optionable.

Bought the shares $16.69
Expect share dilution $40-$50

GLHF
- DPT

Emir iptal

⋅ 1 Haz 2021 15:31

Yorumlar

brandonlee485

⋅ 11 Haz 2021 03:41

You closed your trade too early lol.

brandonlee485

⋅ 31 May 2021 07:45

Have you been able to find a utilization rate for this stock?

Wilson5s

⋅ 27 May 2021 23:12

when do you think this bad boy can squueze?

Daha Fazla